Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) has announced the availability of its fourth quarter and fiscal year 2025 financial results, which ended March 29, 2025, on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on May 8, 2025, at 8:00 a.m. ET to discuss the results.
The company has provided access to supplemental materials including the earnings release and tables supporting fiscal 2026 total Company and Hospital reported and organic revenue growth guidance. A replay of the conference call will be available for one year starting May 8, 2025, at 11:00 a.m. ET.
Haemonetics Corporation (NYSE: HAE) ha annunciato la pubblicazione dei risultati finanziari del quarto trimestre e dell'intero esercizio 2025, conclusosi il 29 marzo 2025, disponibili sul sito web delle Relazioni con gli Investitori. La società terrà una conference call e una webcast con investitori e analisti il 8 maggio 2025 alle 8:00 ET per discutere i risultati.
La società ha reso disponibili materiali supplementari, tra cui il comunicato sugli utili e le tabelle a supporto delle previsioni di crescita dei ricavi totali e organici per l'anno fiscale 2026, sia a livello aziendale che ospedaliero. La registrazione della conference call sarà accessibile per un anno a partire dall'8 maggio 2025 alle 11:00 ET.
Haemonetics Corporation (NYSE: HAE) ha anunciado la disponibilidad de sus resultados financieros del cuarto trimestre y del año fiscal 2025, que finalizó el 29 de marzo de 2025, en su sitio web de Relaciones con Inversionistas. La compañía realizará una llamada conferencia y una transmisión en vivo con inversores y analistas el 8 de mayo de 2025 a las 8:00 a.m. ET para discutir los resultados.
La empresa ha proporcionado acceso a materiales complementarios, incluyendo el comunicado de ganancias y tablas que respaldan las previsiones de crecimiento de ingresos totales y orgánicos de la Compañía y Hospital para el año fiscal 2026. Una repetición de la llamada conferencia estará disponible durante un año a partir del 8 de mayo de 2025 a las 11:00 a.m. ET.
Haemonetics Corporation (NYSE: HAE)는 2025년 3월 29일 종료된 2025 회계연도 4분기 및 연간 재무 결과를 투자자 관계 웹사이트에 공개했다고 발표했습니다. 회사는 2025년 5월 8일 오전 8시(동부시간)에 투자자 및 애널리스트와 함께 결과를 논의하는 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
회사는 2026 회계연도 전체 회사 및 병원 보고 및 유기적 매출 성장 가이던스를 지원하는 실적 발표 자료 및 표를 포함한 보조 자료에 대한 접근도 제공했습니다. 컨퍼런스 콜 녹음은 2025년 5월 8일 오전 11시(동부시간)부터 1년간 다시 들을 수 있습니다.
Haemonetics Corporation (NYSE : HAE) a annoncé la publication de ses résultats financiers du quatrième trimestre et de l'exercice fiscal 2025, clos le 29 mars 2025, sur son site web Relations Investisseurs. La société organisera une conférence téléphonique et un webcast avec les investisseurs et analystes le 8 mai 2025 à 8h00 ET pour discuter des résultats.
La société a mis à disposition des documents complémentaires, notamment le communiqué des résultats et des tableaux soutenant les prévisions de croissance des revenus totaux et organiques de l'entreprise et des hôpitaux pour l'exercice 2026. Le replay de la conférence téléphonique sera disponible pendant un an à partir du 8 mai 2025 à 11h00 ET.
Haemonetics Corporation (NYSE: HAE) hat die Veröffentlichung der Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2025, das am 29. März 2025 endete, auf seiner Investor-Relations-Website bekanntgegeben. Das Unternehmen wird am 8. Mai 2025 um 8:00 Uhr ET eine Telefonkonferenz und ein Webcast mit Investoren und Analysten abhalten, um die Ergebnisse zu besprechen.
Das Unternehmen hat ergänzende Materialien bereitgestellt, darunter die Gewinnmitteilung und Tabellen zur Unterstützung der Prognosen für das organische und berichtete Umsatzwachstum des gesamten Unternehmens und der Krankenhäuser für das Geschäftsjahr 2026. Eine Aufzeichnung der Telefonkonferenz wird ab dem 8. Mai 2025 um 11:00 Uhr ET für ein Jahr verfügbar sein.
- None.
- None.
Financial release accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 8, 2025. The conference call and webcast can be accessed with the following information:
- Teleconference link:
- https://register-conf.media-server.com/register/BI8b22e12b203a4693bead05f6d9f68d5d
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/4z9yixt9
In addition, the Company has posted to its Investor Relations website the earnings release and certain supplemental tables that will be referenced during the call and include additional information supporting fiscal 2026 total Company and Hospital reported and organic revenue growth guidance.
Direct link to 4Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/89295437-34ea-473c-ae6e-409a07328239
Direct link to Hospital Reported and Organic Revenue Growth Guidance Supplemental Tables:
https://haemonetics.gcs-web.com/static-files/320de990-2769-4b30-beca-eff1ca68bad1
A replay of the conference call and webcast will be available for one year beginning on May 8, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302449085.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) report Q4 and FY 2025 earnings?
How can I access Haemonetics (HAE) Q4 2025 earnings call?
How long will Haemonetics (HAE) Q4 2025 earnings call replay be available?
What supplemental materials has Haemonetics (HAE) provided for Q4 2025 earnings?
